Showing results (1851-1860 of 2,163) with videos related to

Sort By:
Pageof 217
Molecular Metabolism|January 18, 2024
Permanent neonatal diabetes-causing insulin mutations have dominant negative effects on beta cell identityYuwei Zhang, Lina Sui, Qian Du, et al.
Molecular Metabolism|January 18, 2024
TAAR1 agonists improve glycemic control, reduce body weight and modulate neurocircuits governing energy balance and feedingNina Dedic, Lien Wang, Eva Hajos-Korcsok, et al.
Molecular Metabolism|January 7, 2024
ATP7A-dependent copper sequestration contributes to termination of β-CATENIN signaling during early adipogenesisH Yang, E Kabin, Y Dong, et al.
Molecular Metabolism|January 1, 2024
Sestrin2 maintains hepatic immune homeostasis and redox balance partially via inhibiting RIPK3-mediated necroptosis in metabolic dysfunction-associated steatohepatitisJian-Bin Zhang, Qian-Ren Zhang, Qian Jin, et al.
Molecular Metabolism|December 23, 2023
Lysine tRNA fragments and miR-194-5p co-regulate hepatic steatosis via β-Klotho and perilipin 2Yonat Tzur, Katarzyna Winek, Nimrod Madrer, et al.
Molecular Metabolism|December 23, 2023
A forebrain-hypothalamic ER stress driven circuit mediates hepatic steatosis during obesityKatherine Blackmore, Claire J Houchen, Hayk Simonyan, et al.
Molecular Metabolism|March 16, 2024
Loss of GIPR in LEPR cells impairs glucose control by GIP and GIP:GLP-1 co-agonism without affecting body weight and food intake in miceSeun Akindehin, Arkadiusz Liskiewicz, Daniela Liskiewicz, et al.
Molecular Metabolism|March 16, 2024
Scd1 and monounsaturated lipids are required for autophagy and survival of adipocytesHiroyuki Mori, Sydney K Peterson, Rachel C Simmermon, et al.
Molecular Metabolism|March 18, 2024
Intestinal Acyl-CoA synthetase 5 (ACSL5) deficiency potentiates postprandial GLP-1 & PYY secretion, reduces food intake, and protects against diet-induced obesityJohn D Griffin, Ying Zhu, Andrew Reeves, et al.
Molecular Metabolism|December 8, 2023
Evaluation of long acting GLP1R/GCGR agonist in a DIO and biopsy-confirmed mouse model of NASH suggest a beneficial role of GLP-1/glucagon agonism in NASH patientsThomas Monfeuga, Jenny Norlin, Anne Bugge, et al.
Pageof 217